Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2009. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3710977014 | Product containing natamycin in ocular dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3710978016 | Natamycin-containing product in ocular dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing natamycin in ocular dose form (medicinal product form) | Is a | Product containing natamycin (medicinal product) | true | Inferred relationship | Some | ||
| Product containing natamycin in ocular dose form (medicinal product form) | Is a | Ophthalmic antibiotic | false | Inferred relationship | Some | ||
| Product containing natamycin in ocular dose form (medicinal product form) | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
| Product containing natamycin in ocular dose form (medicinal product form) | Has active ingredient | Skin antifungal agent | false | Inferred relationship | Some | ||
| Product containing natamycin in ocular dose form (medicinal product form) | Has active ingredient | Natamycin ophthalmic preparation | false | Inferred relationship | Some | ||
| Product containing natamycin in ocular dose form (medicinal product form) | Has active ingredient | Skin agent | false | Inferred relationship | Some | ||
| Product containing natamycin in ocular dose form (medicinal product form) | Has active ingredient | Natamycin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing natamycin in ocular dose form (medicinal product form) | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
| Product containing natamycin in ocular dose form (medicinal product form) | Has active ingredient | Skin agent | false | Inferred relationship | Some | ||
| Product containing natamycin in ocular dose form (medicinal product form) | Has manufactured dose form | Ocular dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing natamycin in ocular dose form (medicinal product form) | Is a | Ophthalmic anti-infective preparation | false | Inferred relationship | Some | ||
| Product containing natamycin in ocular dose form (medicinal product form) | Is a | Product manufactured as ocular dose form (product) | true | Inferred relationship | Some | ||
| Product containing natamycin in ocular dose form (medicinal product form) | Plays role | Antifungal therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug) | Is a | False | Product containing natamycin in ocular dose form (medicinal product form) | Inferred relationship | Some | |
| Natamycin only product in ocular dose form | Is a | True | Product containing natamycin in ocular dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR